Participant-level data and the new frontier in trial transparency

N Engl J Med. 2013 Aug 1;369(5):468-9. doi: 10.1056/NEJMe1307268.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Access to Information*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Azathioprine / therapeutic use*
  • Clinical Trials as Topic*
  • Cyclophosphamide / therapeutic use*
  • Drug Industry*
  • Humans
  • Immunologic Factors / administration & dosage*
  • Information Dissemination*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab
  • Cyclophosphamide
  • Azathioprine